公开(公告)号：US11020486B2

公开(公告)日：2021-06-01

申请号：US15032773

申请日：2014-10-30

Applicant: 3M Innovative Properties Company

Inventor： Joseph M. Beaurline ,  James M. Elvecrog ,  John P. Vasilakos ,  John Thomas Capecchi ,  Karen Elizabeth Johnson

IPC: A61K47/44 ,  A61K9/00 ,  C07D471/04 ,  A61K31/4745 ,  A61K47/10

Abstract: Injectable formulations comprising ethanol, sesame oil, and an Immune Response Modifier compound are disclosed. Methods of making the formulations and methods of using the formulations for treatment of a disease in a subject, e.g., neoplastic disease, comprising injecting the formulations into a subject hi need of treatment, are also provided.

公开(公告)号：US20150110784A1

公开(公告)日：2015-04-23

申请号：US14580369

申请日：2014-12-23

Applicant: 3M INNOVATIVE PROPERTIES COMPANY

Inventor： Mark A. Tomai ,  Gary W. Gullikson ,  David M. Hammerbeck ,  Elaine A. Egging ,  Michael J. Reiter ,  Christopher D. Gram ,  John P. Vasilakos

IPC: A61K31/4745 ,  A61K39/395 ,  A61K31/573

CPC classification number: A61K31/4745 ,  A61K31/00 ,  A61K31/573 ,  A61K39/3955 ,  A61K39/39566 ,  A61K45/06 ,  A61K2039/505 ,  A61K2300/00

Abstract: The present invention provides therapeutic combinations that include an immune response modifier (IRM) component and an anti-inflammatory component. The inventions further provide methods of treating a condition by administering to one having the condition a therapeutic combination that includes an IRM component and an anti-inflammatory component.

Abstract translation: 本发明提供包括免疫应答调节剂（IRM）组分和抗炎组分的治疗组合。 本发明还提供了通过给予具有包括IRM组分和抗炎组分的治疗组合的患者的治疗病症的方法。

公开(公告)号：US20210244819A1

公开(公告)日：2021-08-12

申请号：US17242578

申请日：2021-04-28

Applicant: 3M INNOVATIVE PROPERTIES COMPANY

Inventor： Joseph M. Beaurline ,  James M. Elvecrog ,  John P. Vasilakos ,  John T. Capecchi ,  Karen E. Johnson

IPC: A61K47/44 ,  A61K9/00 ,  C07D471/04 ,  A61K31/4745 ,  A61K47/10

Abstract: Injectable formulations comprising ethanol, sesame oil, and an Immune Response Modifier compound are disclosed. Methods of making the formulations and methods of using the formulations for treatment of a disease in a subject, e.g., neoplastic disease, comprising injecting the formulations into a subject hi need of treatment, are also provided.